
Avinger AVGR
Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Avinger Langfristige Verbindlichkeiten 2011-2026 | AVGR
Langfristige Verbindlichkeiten Jährlich Avinger
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 12.7 M | 4.14 M | 41 K | 301 K | 546 K | 31 M | 160 M | 134 M | 100 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 160 M | 41 K | 49.2 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
42.5 K | $ 2.2 | -0.9 % | $ 3.43 M | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 10.63 | 1.69 % | $ 1.44 B | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 9.67 | -13.35 % | $ 274 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 12.92 | -1.03 % | $ 1.94 B | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.65 | -4.4 % | $ 35.4 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 8.32 | -0.48 % | $ 597 M | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 71.5 | 0.42 % | $ 106 B | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.81 | -6.16 % | $ 142 M | ||
|
CONMED Corporation
CNMD
|
877 M | $ 37.37 | 0.07 % | $ 1.16 B | ||
|
Establishment Labs Holdings
ESTA
|
53.7 M | $ 65.46 | 0.69 % | $ 1.94 B | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
InMode Ltd.
INMD
|
12.5 M | $ 13.56 | -0.66 % | $ 876 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.33 | - | $ 21.5 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.83 | -2.21 % | $ 395 M | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.44 | -0.05 % | $ 121 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 108.81 | -1.72 % | $ 189 B | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 9.53 | -2.21 % | $ 341 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 270.44 | 0.36 % | $ 7.63 B | ||
|
Myomo
MYO
|
275 K | $ 0.72 | -0.86 % | $ 30.1 M | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 2.06 | -5.07 % | $ 1.25 M | ||
|
AxoGen
AXGN
|
1.61 M | $ 31.08 | -5.1 % | $ 1.43 B | ||
|
Align Technology
ALGN
|
184 M | $ 173.94 | -1.24 % | $ 13 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 8.93 | -1.87 % | $ 688 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 34.39 | 1.93 % | $ 5.12 K | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.79 | 1.34 % | $ 156 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
196 M | $ 0.43 | 9.17 % | $ 44.2 M |